Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00109460 · ClinicalTrials.gov registry record · Phase 2
Tobacco Cessation Field Study for Adults in Recovery - 1
A Phase 2 study, sponsored by Inflexxion.
- Completed
- Registry status
- Phase 2
- Development phase
- 203
- Enrollment target
NCT00109460 is a Phase 2 study that has completed, run by Inflexxion. The registered enrollment target is 203 participants.
The verdict
NCT00109460, a Phase 2 study, has completed, sponsored by Inflexxion.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 203 participants
- Enrollment target
Study Summary
The project's aim is to provide a targeted, computer-administered intervention to facilitate tobacco cessation for clients in alcohol treatment. The main focus of "On the Air: A tobacco cessation program for adults in alcohol recovery" is to reduce tobacco use of clients in alcohol treatment. The program will be offered through inpatient, residential, and outpatient treatment programs to help those struggling with alcohol addiction to understand, reduce, and stop tobacco use. Clients will develop a personalized tobacco cessation plan relevant to their readiness to quit tobacco use. Based on the metaphor of a television network, this tobacco cessation program contains information on personal risks, peer stories, cravings and withdrawal, a variety of interactive activities and tools, and also motivational feedback and tips to assist in the quitting process. Phase I was a proof of concept phase, in which we delivered a prototype CD-ROM on tobacco cessation. Phase II will involve completing the development of a functional CD-ROM tool which will be subjected to a clinical field trial with a group of adults (n=196) in treatment facilities for alcohol recovery. The clinical field study will involve finalizing the content, interface, and interactive features of the CD-ROM. We will also gather satisfaction data from both clients and counselors in the various treatment facilities.
Interventions
- BEHAVIORAL Tobacco Use Disorder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 203 participants |
| Start Date | 2003-03 |
| Est. Completion | 2005-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00109460
The ClinicalTrials.gov registry entry for NCT00109460 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 203 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Inflexxion, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tobacco Use Disorder is the first listed.
NCT00109460 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00109460 about?
NCT00109460 is a clinical study titled "Tobacco Cessation Field Study for Adults in Recovery - 1". The project's aim is to provide a targeted, computer-administered intervention to facilitate tobacco cessation for clients in alcohol treatment. The main focus of "On the Air: A tobacco cessation program for adults in alcohol recovery" is to reduce tobacco use of clients in alcohol treatment. The pr...
What is the current status of trial NCT00109460?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 203 participants. The study started on 2003-03. Estimated completion is 2005-03.
What interventions are being tested in trial NCT00109460?
The interventions under investigation include: Tobacco Use Disorder (BEHAVIORAL).
Who is sponsoring clinical trial NCT00109460?
This trial is sponsored by Inflexxion, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.